Vitiligo
📧 Sign up to get email alerts when something new happens for Vitiligo.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-08-03EMA Authorised: Opzelura (ruxolitinib phosphate) — Incyte Biosciences Distribution B.V.
EMA has authorised Opzelura (ruxolitinib phosphate) for use in vitiligo and atopic dermatitis, with Incyte Biosciences Distribution B.V. as …
-
EMA approval · 2026-07-22EMA Authorised: Opzelura (ruxolitinib phosphate) — Incyte Biosciences Distribution B.V.
EMA has authorised Opzelura (ruxolitinib phosphate) for the treatment of vitiligo in the EU.
-
EMA approval · 2026-06-15EMA Authorised: Opzelura (ruxolitinib phosphate) — Incyte Biosciences Distribution B.V.
The EMA has authorised Opzelura (ruxolitinib phosphate) for a therapeutic area focusing on vitiligo, with Incyte Biosciences Distribution B.…
-
CLINICAL_TRIALS trial_result · 2026-06-09Clinical Trial Update: A Study To Assess Adverse Events and Effectiveness of Upadacitinib Oral Tablets in Adult and Adolescent Participants With Vitiligo [Phase 3]
A Phase 3 clinical trial assessing adverse events and effectiveness of upadacitinib oral tablets in adults and adolescents with vitiligo.
-
CLINICAL_TRIALS trial_result · 2026-04-29Clinical Trial Update: A 52-Week Study to Learn About the Safety and Effects of Ritlecitinib in Participants With Nonsegmental Vitiligo [Phase 3]
A 52-week Phase 3 study evaluating the safety and effects of ritlecitinib in participants with nonsegmental vitiligo.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS research · 2026-04-24Clinical Trial Update: A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo [Phase 2]
A Phase 2b dose-ranging study is evaluating the efficacy and safety of GIA632 for non-segmental vitiligo, with recruitment currently ongoing…
-
CLINICAL_TRIALS research · 2026-04-23Clinical Trial Update: Comparative Study of Microneedling With Topical Minoxidil 5% ± NB-UVB in Stable Vitiligo" [Phase 2]
A Phase 2 clinical trial evaluating microneedling with topical minoxidil 5% with or without NB-UVB phototherapy for stable vitiligo; the stu…
-
CLINICAL_TRIALS withdrawal · 2026-04-21Clinical Trial Update: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of VYN201 Gel in Subjects With Non-segmental Vitiligo. [Phase 2]
A Phase 2 trial evaluating VYN201 Gel in non-segmental vitiligo has been terminated; the sponsor Vyne Therapeutics Inc. reports the study st…
-
CLINICAL_TRIALS research · 2026-04-17Clinical Trial Update: Tyrosine Vs Tacrolimus With NB-UVB in Vitiligo [NA]
Clinical trial update describes a study comparing tyrosine versus tacrolimus with NB-UVB in vitiligo; the trial is currently active but not …
-
CLINICAL_TRIALS trial_result · 2026-04-16Clinical Trial Update: A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo [Phase 2]
A Phase 2 clinical trial evaluating LY4005130 in adults with non-segmental vitiligo is not yet recruiting.
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Vitiligo Registry for Adults and Children in the UK
A UK vitiligo registry trial for adults and children, sponsored by The Royal Wolverhampton Hospitals NHS Trust, is currently not yet recruit…
-
CLINICAL_TRIALS research · 2026-04-09Clinical Trial Update: Study of Umbilical Cord Mesenchymal Stem Cell-Derived Exosomes in Vitiligo [Phase 1, Phase 2]
A Phase 1/Phase 2 clinical trial evaluating umbilical cord mesenchymal stem cell-derived exosomes for vitiligo; the study is not yet recruit…
-
CLINICAL_TRIALS research · 2026-04-08Clinical Trial Update: A Study of Zasocitinib in Adults With Nonsegmental Vitiligo [Phase 2]
A Phase 2 clinical trial evaluating Zasocitinib in adults with nonsegmental vitiligo, currently recruiting.
-
CLINICAL_TRIALS research · 2026-04-03Clinical Trial Update: Comparative Efficacy of hUCMSC-Secretome Delivered Via Microneedling and Intradermal Microinjection as Adjuvant Therapy to NB-UVB in Nonsegmental Vitiligo: A Quasi-Experimental Study [Phase 2, Phase 3]
This clinical trial update outlines a Phase 2/Phase 3 quasi-experimental study assessing whether hUCMSC-secretome delivered by microneedling…
-
CLINICAL_TRIALS research · 2026-03-31Clinical Trial Update: Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients [Phase 2]
Phase 2 study of EI-001 for non-segmental vitiligo is currently recruiting.
-
CLINICAL_TRIALS research · 2026-03-27Clinical Trial Update: A 104-Week Study of Ritlecitinib Oral Capsules in Adults With Nonsegmental Vitiligo (Active and Stable) Tranquillo 2 [Phase 3]
Pfizer is conducting a 104-week Phase 3 study of Ritlecitinib oral capsules in adults with nonsegmental vitiligo (stable and active). The tr…
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Repigmentation Using Apremilast and Phototherapy In Diffuse VITILIGO [Phase 2]
A Phase 2 trial evaluating repigmentation in diffuse vitiligo using apremilast in combination with phototherapy has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Atorvastatin in Active Vitiligo [Phase 2]
A Phase 2 clinical trial evaluating atorvastatin for active vitiligo has completed.
-
CLINICAL_TRIALS trial_result · 2026-03-24Clinical Trial Update: Gastroprotected Superoxide Dismutase in Combination With UVB vs Placebo and UVB for Treating Vitiligo. [NA]
A completed clinical trial evaluated gastroprotected superoxide dismutase in combination with UVB phototherapy versus UVB with placebo for t…
-
EMA approval · 2026-03-23EMA Authorised: Opzelura (ruxolitinib phosphate) — Incyte Biosciences Distribution B.V.
The European Medicines Agency authorised Opzelura (ruxolitinib phosphate) for the treatment of vitiligo, with decision dated 26 February 202…
-
CLINICAL_TRIALS trial_result · 2026-03-20Clinical Trial Update: A Study to Assess the Safety and Efficacy of Ruxolitinib Cream in Participants With Genital Vitiligo [Phase 2]
Phase 2 study assessing the safety and efficacy of topical ruxolitinib cream for nonsegmental vitiligo with genital involvement; results hav…
-
CLINICAL_TRIALS research · 2026-03-20Clinical Trial Update: A Longitudinal Observational Study of Patients Undergoing Therapy for IMISC
This document summarizes an ongoing longitudinal observational study of patients undergoing therapy for IMISC (NCT03661866) across several i…
-
CLINICAL_TRIALS trial_result · 2026-03-18Clinical Trial Update: Translational Assessment of Vitiligo According to Body Locations [NA]
A completed clinical trial investigating translational aspects of vitiligo across different body locations.
-
CLINICAL_TRIALS research · 2026-03-17Clinical Trial Update: Combination Approach With Ritlecitinib and nbUVB Compared to Ritlecitinib Alone for Treating Vitiligo [Phase 2]
A Phase 2 clinical trial is evaluating the combination of ritlecitinib with nbUVB versus ritlecitinib alone for vitiligo, with recruitment n…
-
CLINICAL_TRIALS trial_result · 2026-03-17Clinical Trial Update: A Clinical Study of MK-6194 for the Treatment of Vitiligo (MK-6194-007) [Phase 2]
A phase 2 clinical trial evaluating MK-6194 for non-segmental vitiligo has been terminated, and results were posted on 2026-03-17.